Abnormal Post-partum Glucose Metabolism After Gestational Diabetes Diagnosed Before or After 24 Weeks of Gestation
NCT01839448 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2025-11-19
Summary
The main objective of the study is to estimate and compare the percentage of patients with abnormal glucose metabolism at 4-12 weeks postpartum between two groups: patients diagnosed with gestational diabetes before or after 24 weeks of pregnancy. Abnormal glucose metabolism is defined as type 2 diabetes, glucose intolerance or impaired fasting glucose.
Conditions
- Gestational Diabetes
- Type 2 Diabetes
- Glucose Intolerance
Interventions
- BIOLOGICAL
-
Post-partum oral glucose tolerance test
All patients will have an oral glucose tolerance test at 4 to 12 weeks after the end of pregnancy. Study representatives will contact patients by phone to remind them of the necessity of this test, and its importance for their health.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Principal Investigators
-
Valéria Cosma, MD · Centre Hospitalier Universitaire de Nîmes
-
Anne-Marie Guedj, MD · Centre Hospitalier Universitaire de Nîmes
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-27
- Primary Completion
- 2016-10-12
- Completion
- 2016-10-12
Countries
- France
Study Locations
More Related Trials
-
Immediate Postpartum Glucose Tolerance Testing
NCT04199676 ·Status: RECRUITING
-
Oral Glucose Tolerance Testing After Gestational Diabetes
NCT02082301 ·Status: COMPLETED
-
Metabolic Risk and Life Style Factors in Women With Previous Gestational Diabetes Mellitus (GDM)
NCT03050645 ·Status: COMPLETED
-
Postpartum Glycemia in Women At Risk for Persistent Hyperglycemia
NCT04521712 ·Status: COMPLETED ·Phase: NA
-
Association Between CGM Metrics in Type 2 Diabetes Pregnancy and Perinatal Morbidity
NCT06892314 ·Status: COMPLETED
-
Pilot Study of Continuous Glucose Monitoring for Postpartum Glucose Screening
NCT07332416 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Lipophilic Micronutrients, Adipokines and Gestational Diabetes Mellitus
NCT01678469 ·Status: COMPLETED ·Phase: NA
-
Postpartum Screening of Type 2 Diabetes
NCT01869608 ·Status: COMPLETED ·Phase: NA
-
Pregnancy and Postpartum CGM in GDM
NCT07174245 ·Status: RECRUITING
-
Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes
NCT05981547 ·Status: ACTIVE_NOT_RECRUITING
-
Comprehensive Postpartum Screening Strategies for Women With Gestational Diabetes Mellitus (GDM)
NCT00849849 ·Status: COMPLETED
-
Effectiveness of CGMS Vs. Self-monitoring Blood Glucose (SMBG) in Woman with Gestational Diabetes
NCT04948112 ·Status: COMPLETED ·Phase: NA
-
Estimate Rate of the Women Who Have Gestational Diabetes
NCT02852980 ·Status: COMPLETED
-
Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus
NCT02596932 ·Status: COMPLETED ·Phase: NA
-
Glucose Variability in Pregnancy Complicated by Diabetes
NCT01883622 ·Status: COMPLETED
-
Study to Prevent Dysglycemia in Women With GDM
NCT07269405 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Women With Minor Degrees of Glucose Intolerance and the Postpartum Glucose Tolerance Test
NCT03623412 ·Status: UNKNOWN ·Phase: NA
-
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
NCT06643351 ·Status: RECRUITING ·Phase: NA
-
The Effect of Real-time Continuous Glucose Monitoring on Severe Complications to Pregnancy in Women With Diabetes
NCT00994357 ·Status: COMPLETED ·Phase: NA
-
Late Gestational Diabetes Mellitus Diagnosis in Obese Women
NCT05510518 ·Status: UNKNOWN
-
Early Gestational Diabetes Mellitus
NCT04451915 ·Status: UNKNOWN ·Phase: NA
-
Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational Diabetes
NCT07034261 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Early Prediction of Postpartum Glucose Metabolism Abnormalities in Gestational Diabetes Mellitus
NCT05670548 ·Status: RECRUITING
-
Follow up Glucose Levels Among Infants of Diabetic Mothers
NCT00337142 ·Status: COMPLETED
-
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
NCT05909046 ·Status: RECRUITING ·Phase: NA